U.S. FDA SCIENTIST SAYS ANY REGULATORY ACTION ON ADDITIONAL DOSES WOULD RELY UPON SUBMISSION OF SUPPORTIVE DATA TO THE AGENCY - ACIP MEETING
Stock Market News in real time
- Stock Market
- Stock Market News in real time
- Economy
- U.s. Fda Scientist Says Any Regulatory Action On Additional Doses Would Rely Upon Submission Of Supportive Data To The Agency - Acip Meeting